Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis

Clinical trial NCT06961383 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06961383
Sponsor: NeuroGenesis Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Secondary Progressive Multiple Sclerosis (SPMS)

Start date: 2025-10-01
Primary completion: 2027-10-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.